Tag: cohort
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study
Sequelae symptoms Any of the following symptoms 777/1149 (68%) 583/1188 (49%) * p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up. 650/1190 (55%) † p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up. ‡ p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up. 194/286 (68%) 141 (48%) * p<4·17 × 10−3 for the comparison of 12-month with
A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform
Abstract Background There is concern about medium to long-term adverse outcomes following acute Coronavirus Disease 2019 (COVID-19), but little relevant evidence exists. We aimed to investigate whether risks of hospital admission and death, overall and by specific cause, are raised following discharge from a COVID-19 hospitalisation. Methods and findings With the approval of NHS-England, we
A cohort study in the UK Biobank
Abstract Background Previous studies have revealed the involvement of coffee and tea in the development of stroke and dementia. However, little is known about the association between the combination of coffee and tea and the risk of stroke, dementia, and poststroke dementia. Therefore, we aimed to investigate the associations of coffee and tea separately and
Alcohol abstinence and mortality in a general population sample of adults in Germany: A cohort study
Abstract Background Evidence suggests that people who abstain from alcohol have a higher mortality rate than those who drink low to moderate amounts. However, little is known about factors that might be causal for this finding. The objective was to analyze former alcohol or drug use disorders, risky drinking, tobacco smoking, and fair to poor
A 6-month retrospective cohort study of 273,618 survivors of COVID-19
Abstract Background Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of infection, and the extent to which they are specific to
A cohort study, systematic review, and meta-analysis
Abstract Background We aimed to investigate the association of serum pentadecanoic acid (15:0), a biomarker of dairy fat intake, with incident cardiovascular disease (CVD) and all-cause mortality in a Swedish cohort study. We also systematically reviewed studies of the association of dairy fat biomarkers (circulating or adipose tissue levels of 15:0, heptadecanoic acid [17:0], and